SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cummings CW, Goodman ML. Inverted papillomas of the nose and paranasal sinuses. Arch Otolaryngol Head Neck Surg 1970; 92: 4459.
  • 2
    Snyder RN, Perzin KH. Papillomatosis of nasal cavity and paranasal sinuses (inverted papilloma, squamous papilloma): a clinicopathologic study. Cancer 1972; 30: 66890.
  • 3
    Ridolfi RL, Lieberman PH, Erlandson RA, Moore OS. Schneiderian papillomas: a clinicopathologic study of 30 cases. Am J Surg Pathol 1977; 1: 4353.
  • 4
    Woodson GE, Robbins KT, Michaels L. Inverted papilloma: considerations in treatment. Arch Otolaryngol Head Neck Surg 1985; 111: 80611.
  • 5
    Phillips PP, Gustafson RO, Facer GW. The clinical behavior of inverting papilloma of the nose and paranasal sinuses: report of 112 cases and review of the literature. Laryngoscope 1990; 100: 4639.
  • 6
    Bielamowicz S, Calcaterra TC, Watson D. Inverting papilloma of the head and neck: UCLA update. Otolaryngol Head Neck Surg 1993; 109: 716.
  • 7
    Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 16218.
  • 8
    Maruo T, Shibata K, Kimura A, Hoshima A, Mochizuki M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Cancer 1985; 59: 3028.
  • 9
    Brioschi PA, Bischof P, Delafosse C, Krauer F. Squamous cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical cancer. Int J Cancer 1991; 47: 3769.
  • 10
    Lara PC, Cuyas JM. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 1995; 76: 75864.
  • 11
    Molina R, Torres MD, Moragas M, Perez-Villa J, Filella X, Jo J, et al. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer. Tumour Biol 1996; 17: 819.
  • 12
    Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A. Cyfra 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res 1996; 16: 311724.
  • 13
    Sanchez De Cos J, Masa F, de la Cruz JL, Disdier C, Vergara C. Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 1994; 105: 7736.
  • 14
    Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H, Sugimachi K. Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein cells in human malignant esophageal tissues. Cancer 1990; 65: 22615.
  • 15
    Kudo H, Yamamoto M, Miyachi Y, Danno K, Imamura S. Increased serum levels of squamous cell carcinoma-related antigen in pemphigus. Br J Dermatol 1988; 118: 4714.
  • 16
    Numahara T, Nakashima K, Yamamoto S, Nishimoto M. Significance of squamous cell carcinoma-related antigen in psoriasis and generalized eczema. Dermatologica 1989; 178: 734.
  • 17
    Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 1989; 64: 16526.
  • 18
    Campbell B, De'Ambrosis B. Squamous cell carcinoma antigen in patients with cutaneous disorders. J Am Acad Dermatol 1990; 22: 63942.
  • 19
    Sedona P, Bassi R, Fabbian PR. Valutazione dello squamous cell carcinoma associated antigen (SCC) nelle dermopatie-Resultati preliminari. Acta Oncol 1993; 14: 816.
  • 20
    Quadri G, Torre GC, Lanfranco E. Erythemato, squamous, chronic dermatoses, psoriasis: a misleading factor of the interpretation of elevated levels of SCC antigen. Tumour Biol 1993; 13: 12.
  • 21
    Suzuki K, Suzuki T, Akiyama Y, Takashima Y, Yamada T, Kawashima Y, et al. Serum and pleural SCC-antigen levels in patients with pulmonary tuberculosis. Kekkaku 1993; 68: 5517.
  • 22
    Ashitani J, Mukae H, Ihiboshi H, Taniguchi H, Mashimoto H, Motsukura S. Adult respiratory distress syndrome with increased serum and bronchoalveolar lavage fluid levels of squamous cell carcinoma-related antigen. Intern Med 1996; 35: 497501.
  • 23
    Sakito O, Kodota J, Kohno S, Itoh N, Takehara D, Hara K. Pulmonary infiltration with eosinophilia and increased serum levels of squamous cell carcinoma-related antigen and neuron specific enolase. Intern Med 1994; 33: 5503.
  • 24
    Bando M, Tani K, Kohrai F, Sano T, Kitamura S. A case of sarcoidosis with elevated SCC antigen in the serum and broncho-alveolar lavage fluid which was difficult to distinguish from lung cancer. Nippon Kyobu Shikkan Gakkai Zasshi 1994; 32: 95100.
  • 25
    Tatsuta M, Nishi T, Yamada T, Ikeda M, Inui I, Hoshi O, et al. A case of bronchogenic cyst in the posterior mediastinum with high level of serum SCC antigen. Kyobu Geka 1993; 46: 6235.
  • 26
    Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995;92: 314751.
  • 27
    Cataltepe S, Schick C, Luke CJ, Pak SC, Goldfarb D, Chen P, et al. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor makers SCCA1 and SCCA2. Clin Chim Acta 2000; 295: 10727.
  • 28
    Suminami Y, Kishi F, Sekiguchi K, Kato H. Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991; 181: 518.
  • 29
    Crombach G, Scharl A, Vierbuchen M, Wurz H, Bolte A. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer 1989; 63: 133742.
  • 30
    Cataltepe S, Gornstein ER, Schick C, Kamachi Y, Chatson K, Fries J, et al. Coexpression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem 2000; 48: 11322.
  • 31
    Yasumatsu R, Nakashima T, Azuma K, Hirakawa N, Kuratomi Y, Tomita K, et al. SCCA1 expression in T-lymphocytes peripheral to cancer cells is associated with the elevation of serum SCC antigen in squamous cell carcinoma of the tongue. Cancer Lett 2001; 167: 20513.
  • 32
    Lespererance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 1995; 105: 17883.
  • 33
    Nakashima T, Pak SC, Silverman GA, Spring PM, Frederick MJ, Clayman GL. Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. Biochim Biophys Acta 2000; 24: 4416.
  • 34
    Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng SJ, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000; 11: 2398403.
  • 35
    Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, et al. Cross-class inhibition of the cysteine proteinases cathepsin K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 1998; 37: 525866.
  • 36
    Lippman SM, Matrisian LM. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res 2000; 6: 4599603.